271 related articles for article (PubMed ID: 12089572)
1. Private company profiles.
Nat Biotechnol; 2002 Jul; 20 Suppl():BE15-21. PubMed ID: 12089572
[No Abstract] [Full Text] [Related]
2. Private company profiles.
Nat Biotechnol; 2003 Jul; 21 Suppl():BE23-8. PubMed ID: 12874973
[No Abstract] [Full Text] [Related]
3. Biotechnology's metamorphosis into a drug discovery industry.
Drews J
Nat Biotechnol; 1998 May; 16 Suppl():22-4. PubMed ID: 9591258
[No Abstract] [Full Text] [Related]
4. The evolving role of collaboration in biotechnology.
Gower JM
Nat Biotechnol; 1998 May; 16 Suppl():31-2. PubMed ID: 9591261
[No Abstract] [Full Text] [Related]
5. The power of genomics to transform the biotechnology industry.
Haseltine WA
Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259
[No Abstract] [Full Text] [Related]
6. In silico drug discovery: tools for bridging the NCE gap.
Larvol BL; Wilkerson LJ
Nat Biotechnol; 1998 May; 16 Suppl():33-4. PubMed ID: 9591262
[No Abstract] [Full Text] [Related]
7. Deal watch: Trends in platform technology deal-making.
Walker J; Jacob J
Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
[No Abstract] [Full Text] [Related]
8. Cancer nanotechnology: small, but heading for the big time.
Nat Rev Drug Discov; 2007 Mar; 6(3):174-5. PubMed ID: 17396287
[No Abstract] [Full Text] [Related]
9. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
Razvi ES
IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
[No Abstract] [Full Text] [Related]
10. Carlo Incerti.
Incerti C
Nat Rev Drug Discov; 2008 Aug; 7(8):638. PubMed ID: 18670428
[No Abstract] [Full Text] [Related]
11. In the pursuit of industrial proteomics.
Mitchell P
Nat Biotechnol; 2003 Mar; 21(3):233-7. PubMed ID: 12610565
[No Abstract] [Full Text] [Related]
12. Bioentrepreneurship around the world.
Persidis A
Nat Biotechnol; 1998 May; 16 Suppl():3-4. PubMed ID: 9591247
[No Abstract] [Full Text] [Related]
13. Lessons from 54 years of pharmaceutical research.
Firestone RA
Nat Rev Drug Discov; 2011 Oct; 10(12):963. PubMed ID: 22036986
[No Abstract] [Full Text] [Related]
14. In biomarkers we trust?
Baker M
Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
[No Abstract] [Full Text] [Related]
15. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
16. Biopharmaceutical benchmarks--2003.
Walsh G
Nat Biotechnol; 2003 Aug; 21(8):865-70. PubMed ID: 12894198
[No Abstract] [Full Text] [Related]
17. Venturing into drug discovery.
Steinmetz M
Nat Biotechnol; 1998 May; 16 Suppl():17. PubMed ID: 9591255
[No Abstract] [Full Text] [Related]
18. Antibacterial drug discovery: is small pharma the solution?
Boggs AF; Miller GH
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038
[TBL] [Abstract][Full Text] [Related]
19. Sunbaked biotechnology in Australia.
Littlejohn T
Nat Biotechnol; 2002 Sep; 20(9):873-7. PubMed ID: 12205502
[No Abstract] [Full Text] [Related]
20. Trends in biopharmaceutical IPOS: 1996-2005.
Williams DR; Young CC
J Health Care Finance; 2006; 33(2):39-54. PubMed ID: 19175239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]